Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tandem Diabetes Care

20.23
-0.5500-2.65%
Post-market: 20.01-0.2168-1.07%19:53 EDT
Volume:1.23M
Turnover:25.09M
Market Cap:1.35B
PE:-7.23
High:20.98
Open:20.98
Low:20.19
Close:20.78
Loading ...

Tandem Diabetes Care: Strategic Initiatives and Product Launches Drive Long-Term Growth Potential

TIPRANKS
·
06 Jun

Healthcare Technology Stocks Q1 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

StockStory
·
30 May

Goldman Sachs Sticks to Their Hold Rating for Tandem Diabetes Care (TNDM)

TIPRANKS
·
30 May

BUZZ-Tandem climbs on $36 million settlement agreement with Roche

Reuters
·
24 May

Tandem Diabetes Agrees to Pay Roche $36M in Patent Infringement Deal

Dow Jones
·
24 May

Tandem Diabetes Care Settles Patent Disputes with Roche

TIPRANKS
·
24 May

BRIEF-Tandem Diabetes Care Inc - Enters Settlement Agreement With Roche Entities - SEC Filing

Reuters
·
24 May

Tandem Diabetes, Roche enter patent settlement agreement

TIPRANKS
·
24 May

Tandem Diabetes Care Inc - Enters Settlement Agreement With Roche Entities - SEC Filing

THOMSON REUTERS
·
24 May

Tandem Diabetes Care Inc. Conducted Virtual Annual Meeting of Stockholders

Reuters
·
24 May

Tandem Diabetes Care Is Maintained at Neutral by Citigroup

Dow Jones
·
23 May

Citi ups Tandem target, adds ‘upside 90-day short-term view’

TIPRANKS
·
22 May

Tandem Diabetes Care Gains CE Mark Approval

TIPRANKS
·
20 May

Tandem Diabetes Care Inc. Receives CE Mark Approval for Tandem Mobi Insulin Delivery System with Control-IQ+ Technology, Plans EU Launch by End of 2025

Reuters
·
20 May

Tandem Diabetes Care Inc. Receives FDA Clearance for SteadiSet Infusion Set for Up to Three Days of Use

Reuters
·
13 May

Stock Track | Tandem Diabetes Care Stock Soars 5% on Strong Q1 Revenue Growth Despite Earnings Miss

Stock Track
·
02 May

Tandem Diabetes Care Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
02 May

Stock Track | Tandem Diabetes Care Soars 14.54% on Strong Q1 Results and Robust Global Growth

Stock Track
·
01 May

Tandem Diabetes Care Is Maintained at Neutral by Baird

Dow Jones
·
01 May

Stock Track | Tandem Diabetes Care Soars 9.79% Pre-market on Stellar Q1 Results and Strong Growth Outlook

Stock Track
·
01 May